| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-08-04 | NCT07744802 Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male… | Phase 1 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05734105 | A Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon… | GIST | Active, Not Recruiting |
| NCT03673501 | A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib | Gastrointestinal Stromal Tumors | Active, Not Recruiting |
| NCT05059262 | Study of Vimseltinib for Tenosynovial Giant Cell Tumor | Tenosynovial Giant Cell Tumor | Active, Not Recruiting |
| Phase 2 | |||
| NCT06619561 | A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease… | Chronic Graft-Versus-Host Disease (cGVHD) | Recruiting |
| Phase 1/2 | |||
| NCT06630234 | A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) | Gastrointestinal Stromal Tumor (GIST) | Recruiting |
| NCT05957367 | A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in… | GIST | Recruiting |
| NCT03069469 | Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant… | Advanced Malignant Neoplasm | Active, Not Recruiting |
| Phase 1 | |||
| NCT07539090 | Evaluate the Effect of Vimseltinib on Pharmacokinetics of Combined Oral Contraceptive… | Healthy Participants | Recruiting |
| NCT06966024 | Study of DCC-2812 in Participants With Advanced Genitourinary Cancers | Renal Cell Carcinoma | Recruiting |
| NCT07744802 | Evaluate the Effect of Vimseltinib on P-glycoprotein (P-gp) Inhibition in Healthy Male… | Healthy Male Participants | Not Yet Recruiting |
| Not specified | |||
| NCT07075471 | MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With… | Tenosynovial Giant Cell Tumor | Recruiting |